Samsung Healthcare Expands Imaging Portfolio With New GC85A Fit and Unified Ultrasound Platform

According to Samsung, the system is designed to support routine imaging requirements while allowing healthcare facilities to adapt their radiography infrastructure to changing operational needs.

Samsung Healthcare will introduce its GC85A Fit radiography system and showcase advancements across its ultrasound portfolio, including a unified software architecture, AI-powered imaging technologies, and mobile CT systems, at the 2026 Radiological Society of North America (RSNA) Annual Meeting.

The GC85A Fit is a semi-automated, ceiling-mounted radiography system designed for emergency and trauma departments, orthopedic practices, and general radiography environments. It combines flexible configurations with streamlined workflows and imaging capabilities to accommodate different clinical settings and room layouts.

According to Samsung, the system is designed to support routine imaging requirements while allowing healthcare facilities to adapt their radiography infrastructure to changing operational needs.

A key development across Samsung's ultrasound portfolio is the unification of its premium and compact systems under a common software architecture. The shared platform is intended to provide consistent touchscreen interfaces and workflows across different systems, helping sonographers and radiologists transition between devices with less training.

The common software foundation is also expected to support faster development and deployment of new technologies across the portfolio. Samsung's ultrasound systems feature Windows 11 and an advanced computing architecture designed to strengthen cybersecurity and support AI scalability.

At the RSNA 2026 Annual Meeting, Samsung will also showcase its X10 tablet ultrasound system*, which features simplified workflows and battery-powered mobility. The company will present advancements to its R20 ultrasound platform, including AI-powered Deep USFF* for liver fat quantification and viscosity imaging technology for noninvasive liver disease assessment.

Additional AI Assist* tools will be demonstrated to streamline examinations, improve reproducibility, and support clinical productivity.

"Listening to our customers and understanding their evolving needs is fundamental to how we approach innovation at Samsung," said Jeyul Chang, Head of Sales & Marketing Team, Health & Medical Equipment Business at Samsung Electronics.

The company's exhibition will also include its mobile CT portfolio. BodyTom 64 features battery-powered scanning, an 85 cm bore, an independent workstation, and Instant Repeat capability, allowing imaging across different care settings without fixed installation.

Samsung will also showcase OmniTom PCD, which uses photon-counting detector technology to deliver high-resolution imaging at low radiation doses and support expanded image analysis and diagnostic capabilities.

"Healthcare organizations shouldn't have to choose between advanced imaging technology and responsible capital investment," said Tracy Bury, Chief Commercial Officer, Samsung Healthcare USA.

Stay tuned for more such updates on Digital Health News